Add BrightSurf on Google Email

Medication treatment for opioid use disorder offered at only a third of outpatient mental health facilities

A new RAND study found that only a third of outpatient community mental health treatment facilities in the US offer medication treatment for opioid use disorders. Clinics with integrated mental and substance use disorder treatment were more likely to provide such services. The findings suggest efforts are needed to strengthen these ser...

SourceRAND Corporation·JournalJAMA Network Open·TypeSurvey·DateJun 18, 2024

NIH-funded intervention did not impact opioid-related overdose death rates over evaluation period

The NIH-funded HEALing Communities Study found that a data-driven intervention did not significantly reduce opioid-related overdose deaths, despite engaging communities in evidence-based practices. The study suggests that factors like the COVID-19 pandemic and increasing fentanyl presence may have weakened the impact of the intervention.

SourceNIH/National Institute on Drug Abuse·JournalNew England Journal of Medicine·DateJun 16, 2024

Clinical trial shows promising results in a two-drug combination that curbs methamphetamine use

A clinical trial shows that a combination of injectable naltrexone and extended-release oral bupropion reduces methamphetamine use for up to 12 weeks. The study found a significant increase in methamphetamine-negative urine tests among participants receiving the two-drug therapy.

SourceUniversity of California - Los Angeles Health Sciences·JournalAddiction·TypeRandomized controlled/clinical trial·DateJun 10, 2024

Methods to quit smoking effective regardless of mental health history

A survey of over 5,000 smokers found that mental health conditions do not affect the effectiveness of smoking cessation aids. The most effective aids were vaping products, varenicline, and heated tobacco products, with no differences in efficacy between people with mental health conditions.

SourcePLOS·JournalPLOS Mental Health·TypeSurvey·DateJun 4, 2024

San Francisco study explores the growing culture of fentanyl smoking

A new study explores the growing fentanyl smoking culture in San Francisco, highlighting individual experiences and local trends. Participants reported fear of overdose and challenges with injecting as motivations for switching to smoking, but some expressed concerns about hygiene and residue risks.

SourcePLOS·JournalPLOS ONE·TypeObservational study·DateMay 22, 2024

It’s easier now to treat opioid addiction with medication -- but use has changed little

A new study found that the elimination of a federal waiver requirement increased the number of clinicians prescribing buprenorphine, but didn't lead to a sharp rise in patient treatment. By December 2023, over 53,600 clinicians had prescribed buprenorphine, but numbers remained stable compared to 2022.

SourceMichigan Medicine - University of Michigan·JournalNew England Journal of Medicine·TypeData/statistical analysis·DateApr 24, 2024

A common pathway in the brain that enables addictive drugs to hijack natural reward processing has been identified by Mount Sinai

Researchers have uncovered a mechanism in the brain that allows cocaine and morphine to take over natural reward processing systems. A largely overlapping population of cells respond to both addictive drugs and natural rewards, leading to behavior directed toward drug-seeking and away from natural rewards.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalScience·TypeExperimental study·DateApr 18, 2024

Heavy alcohol, drug use linked to increased risk of falls among people with HIV

A new study has found that heavy alcohol use and illicit opioid use are linked to a higher risk of falls and fractures among people living with HIV. The study suggests the need for targeted clinical screening and interventions to prevent falls and related injuries, particularly among populations already at risk.

SourceBoston University School of Public Health·JournalJAIDS Journal of Acquired Immune Deficiency Syndromes·TypeObservational study·DateFeb 21, 2024

Researchers develop rapid test for detecting fentanyl

University of Texas at Dallas researchers have developed a first-of-its-kind, handheld electrochemical sensor that can accurately detect fentanyl in urine within seconds. The device detects even trace amounts of fentanyl with 98% accuracy and could be used to test for the drug in saliva, helping first responders make treatment decisions.

SourceUniversity of Texas at Dallas·JournalACS Applied Materials & Interfaces·TypeExperimental study·DateFeb 5, 2024

Psychology research: Women more sensitive to cocaine

A recent study by researchers at the University of Texas at Arlington found that women are more susceptible to cocaine addiction than men due to fluctuations in sex hormones. The study discovered that the female sex hormone estradiol enhances the rewarding effects of cocaine, leading to increased sensitivity among females.

SourceUniversity of Texas at Arlington·JournalPharmacology Biochemistry and Behavior·TypeExperimental study·DateJan 29, 2024

Cannabis has no clear effect on treatment of opioid addiction, US study finds

A new peer-reviewed study suggests that cannabis is having no significant effect on people's use of opioids, taken outside of medical guidance. The findings have substantial implications for U.S. treatment programs, which still require patients to abstain from cannabis before qualifying for potentially life-saving treatment.

SourceTaylor & Francis Group·JournalThe American Journal of Drug and Alcohol Abuse·TypeSystematic review·DateJan 16, 2024

Mount Sinai study shows that human beliefs about drugs could have dose-dependent effects on the brain

A Mount Sinai study found that human beliefs about nicotine can modulate brain activities in a way comparable to pharmacology, with potential implications for addiction treatment. The study used fMRI to explore the relationship between subjective beliefs and biological substrates in the human brain.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Mental Health·TypeObservational study·DateJan 3, 2024

Like kids in a candy store

Researchers at Kyoto University analyzed queries on Yahoo! Chiebukuro and found that users were seeking information on overdosing from OTCs to alleviate physical pain or experience psychosomatic changes. The study highlights the need for reliable information on OTC abuse to be effectively disseminated.

SourceKyoto University·JournalJMIR Formative Research·TypeData/statistical analysis·DateDec 22, 2023

Substance abuse treatment helps reduce reported methamphetamine use among men who have sex with men

A UCLA study found that substance abuse treatment can lead to reduced methamphetamine usage and longer periods of abstinence. The study, which analyzed responses from nearly 300 men in Los Angeles, suggests that even limited treatment options can be effective in reducing methamphetamine use.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of Substance Use and Addiction Treatment·TypeObservational study·DateNov 29, 2023

The University of Oklahoma and Oklahoma State University collaboration finds semaglutide treatment is associated with remarkable reductions in Alcohol Use Disorder symptoms

A case series published in The Journal of Clinical Psychiatry reveals semaglutide's potential therapeutic applications in managing Alcohol Use Disorder, demonstrating significant reductions in AUDIT scores. Further research is needed to validate these findings through larger clinical trials.

SourceUniversity of Oklahoma·JournalThe Journal of Clinical Psychiatry·DateNov 27, 2023

Researchers uncover molecular mechanism of methamphetamine binding to trace amine receptor TAAR1

A study published in Nature reveals the molecular mechanism of methamphetamine binding to the trace amine receptor TAAR1, which plays a crucial role in modulating monoaminergic systems. The researchers used cryo-electron microscopy to determine high-resolution structures of the human TAAR1-Gs protein complex stimulated by methamphetamine.

States with legalized medical marijuana see decline in nonmedical opioid use

A Rutgers study found that states with legalized medical marijuana experience a 0.5 to 1.5 percentage point decrease in regular nonmedical prescription opioid use among people who reported using opioids in the previous year. However, this reduction is concentrated in individuals with cannabis addiction, highlighting the need for compre...

SourceRutgers University·JournalInternational Journal of Mental Health and Addiction·TypeData/statistical analysis·DateNov 14, 2023

Treating amphetamine use disorder with stimulants: an encouraging new approach

A new meta-analysis suggests that high-dose prescription psychostimulants like methylphenidate and dextroamphetamine can lower cravings and reduce stimulant use in people with amphetamine-type stimulant use disorder. The study analyzed ten randomized controlled trials and found that effects may increase with higher dosage.

SourceSociety for the Study of Addiction·JournalAddiction·TypeMeta-analysis·DateOct 26, 2023

Are opioid prescription rates changing for US adolescents?

Rates of opioid prescribing to US adolescents have decreased in recent years, mainly for non-surgical procedures. Opioid prescribing for surgical indications has remained relatively stable during the same period. This analysis of Medical Expenditure Panel Surveys data from 2015-2020 reveals a significant shift in prescribing patterns.

SourceWiley·JournalPediatric Anesthesia·DateOct 4, 2023

Addressing social determinants of health in post-overdose outreach associated with greater reduction in fatal opioid overdoses

New research from Boston Medical Center's Grayken Center for Addiction found that municipalities offering wide-ranging social services to overdose survivors saw a 21% decrease in fatal overdoses. The study suggests connections to housing, food, employment, and transportation may be key to successful post-overdose outreach programs.

SourceBoston Medical Center·JournalInternational Journal of Drug Policy·DateSep 14, 2023

Overdose deaths from fentanyl laced stimulants have risen 50-fold since 2010

US overdose deaths involving fentanyl and stimulants increased 50-fold from 2010 to 2021, with stimulants becoming most common drug class found in fentanyl-involved overdoses. The trend disproportionately affects racial/ethnic minority communities, particularly Black and African American people.

SourceUniversity of California - Los Angeles Health Sciences·JournalAddiction·TypeData/statistical analysis·DateSep 14, 2023

Nicotine e-cigarettes, prescription drugs and dual nicotine replacement therapy identified as most effective stop-smoking aids

A comprehensive global analysis found that these stop-smoking aids are nearly twice as effective as single forms of NRT. Dual forms of NRT, such as combining a patch with gum or a lozenge, were found to be nearly as effective as nicotine e-cigarettes and prescription medications.

SourceUniversity of Massachusetts Amherst·JournalCochrane Database of Systematic Reviews·TypeData/statistical analysis·DateSep 12, 2023

Sahmyook University researchers identify genes associated with addiction to psychostimulant drugs

Sahmyook University researchers discovered a correlation between methamphetamine-induced behavior and the expression of specific genes in mice models lacking Period 2 gene. They identified 19 genes that were activated only in response to repeated doses of methamphetamine.

SourceSahmyook University·JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry·TypeExperimental study·DateSep 7, 2023

Street medicine filling a major gap by providing behavioral health care for people who are homeless

A new survey by USC Street Medicine found that street medicine programs are helping to fill the gap in access to mental health and substance use treatments for unhoused individuals in California. The study suggests that these programs can serve as a strategy to expand access to behavioral health care for people who are unsheltered.

SourceKeck School of Medicine of USC·JournalCommunity Mental Health Journal·TypeSurvey·DateSep 6, 2023